Loading company details...
Beta
Latest Form 4 (Sep 9, 2026): Daniel Scott Ory (EVP, Chief Medical Officer): Grant/Award of 950,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Daniel Scott Ory, EVP, Chief Medical Officer | Grant/Award | 950,000 | n/a |
| Sep 4, 2026 | Linda Burkly, EVP, CHIEF SCIENTIFIC OFFICER | Sale | 709 | $2.2K |
| Sep 4, 2026 | Amy Parison, SVP, Chief Financial Officer | Sale | 453 | $1.4K |
| Sep 4, 2026 | Gilmore Neil O'Neill, CEO | Sale | 5,124 | $15.6K |
| Aug 7, 2026 | Patrick Thomas Ellinor II | Grant/Award | 103,400 | n/a |
| Aug 5, 2026 | Amy Parison, SVP, Chief Financial Officer | Sale | 678 | $1.7K |
| Jul 29, 2026 | Linda Burkly, EVP, CHIEF SCIENTIFIC OFFICER | Sale | 4,928 | $13.2K |
| Jun 22, 2026 | Bernadette Connaughton | Grant/Award | 51,700 | n/a |
| Jun 22, 2026 | Jessica Hopfield | Grant/Award | 51,700 | n/a |
| Jun 22, 2026 | Andrew Hirsch | Grant/Award | 51,700 | n/a |